Global Concussions Market to Reach USD 10,782.84 Million by 2032 | CAGR of 5.7%
Category : Pharmaceuticals | Published Date : Jan 2025 | Type : Press Release
Concussions Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the concussions market was valued at USD 6,920.75 million in 2024 and is projected to grow at a CAGR of 5.7%, reaching USD 10,782.84 million by 2032. Concussions, classified as mild traumatic brain injuries, result from external impacts causing temporary brain dysfunction. They are commonly linked to sports injuries, accidents, and falls. Key symptoms include headaches, dizziness, memory issues, and difficulty concentrating. Diagnostic methods involve neurological exams, imaging tests (MRI, CT scans), and emerging blood biomarkers. Treatment focuses on symptom management through medications and rehabilitation therapies, while preventive strategies emphasize protective gear and educational programs.
The report comprises the concussions market share, size & industry analysis, based on diagnosis (neurological examination, imaging tests, CT scans, MRI scans, cognitive testing, blood biomarkers), treatment type (medications, rehabilitation therapies), severity (mild concussion, moderate concussion, severe concussion), end-user (hospitals & clinics, rehabilitation centers, sports medicine centers), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and forecast, 2025-2032.
The report contains detailed information on concussions market trends, opportunities, value, growth rate, segmentation, geographical coverage, company profiles, in-depth expert analysis, revenue forecast, competitive landscape, growth factors, restraints or challenges, environment & regulatory landscape, PESTLE analysis, PORTER analysis, key technology landscape, value chain analysis, and cost analysis.
The increasing adoption of neuroimaging for accurate concussion diagnosis and the integration of artificial intelligence (AI) in concussion detection and treatment are driving market growth. Additionally, advancements in blood biomarker technology offer promising opportunities for more precise and early concussion detection.
Segmental Analysis :
Based on diagnosis, the market is segmented into neurological examination, imaging tests, CT scans, MRI scans, cognitive testing, and blood biomarkers.
- Neurological examination accounted for the largest market share in 2024 due to its accessibility, non-invasive nature, and immediate results in concussion assessment.
- Blood biomarkers are expected to register the fastest growth, driven by their precision in detecting brain injuries at the molecular level and the growing focus on personalized medicine.
Based on treatment type, the market is segmented into medications and rehabilitation therapies.
- Medications dominated the market in 2024 due to their critical role in managing concussion symptoms like headaches and dizziness, with a wide availability of generic and branded drugs.
- Rehabilitation therapies are projected to grow at the fastest rate, supported by increasing recognition of physical, cognitive, and speech therapies in comprehensive concussion recovery.
Based on severity, the market is segmented into mild concussion, moderate concussion, and severe concussion.
- Mild concussions held the largest share in 2024 due to their high prevalence in sports injuries and workplace accidents.
- Severe concussions are expected to grow at the fastest rate, driven by advancements in acute care and growing awareness of long-term complications.
Based on end-user, the market is segmented into hospitals & clinics, rehabilitation centers, and sports medicine centers.
- Hospitals & clinics accounted for the largest revenue share of 43.65% in 2024, owing to their access to advanced diagnostic tools and specialized neurology departments.
- Sports medicine centers are anticipated to grow at the fastest rate due to rising awareness of sports-related concussions and increased investments in athlete healthcare.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- North America led the market in 2024, valued at USD 2,295.67 million, due to extensive research, advanced healthcare infrastructure, and high concussion incidence in contact sports.
- Asia-Pacific is projected to register the fastest CAGR of 6.1%, fueled by growing sports participation and improving healthcare infrastructure in countries like Japan, China, and India.
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 10,782.84 Million |
| CAGR (2025-2032) | 5.7% |
| Diagnosis | Neurological examination, imaging tests, CT scans, MRI scans, cognitive testing, blood biomarkers |
| Treatment Type | Medications, rehabilitation therapies |
| Severity | Mild concussion, moderate concussion, severe concussion |
| End-User | Hospitals & clinics, rehabilitation centers, sports medicine centers |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the concussions industry:
- Abbott Laboratories (United States)
- Medtronic PLC (Ireland)
- Johnson & Johnson (United States)
- Stryker Corporation (United States)
- Zimmer Biomet Holdings, Inc. (United States)
- Becton, Dickinson and Company (United States)
- BrainScope Company, Inc. (United States)
- ImPACT Applications, Inc. (United States)
- Cognizant Technology Solutions Corporation (United States)
- Helmholtz Institute (Germany)
Recent Industry Developments :
- September 2024: FIFA and the World Health Organization (WHO) launched the "Suspect and Protect" campaign to raise awareness about concussion risks and promote player safety in football.
- April 2024: BrainScope Company, Inc. expanded its concussion assessment device portfolio with AI-powered algorithms for real-time brain injury detection.
- January 2024: Medtronic PLC partnered with leading hospitals to develop advanced neuroimaging solutions for concussion diagnosis.
